LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.400
-0.080 (-5.41%)
At close: Jul 15, 2025, 4:00 PM
1.400
0.00 (0.00%)
After-hours: Jul 15, 2025, 4:00 PM EDT
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $36.83 million as of July 15, 2025. Its market cap has decreased by -24.29% in one year.
Market Cap
36.83M
Enterprise Value
-27.31M
1-Year Change
-24.29%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $36.83M, a decrease of -90.32%. That is a compound annual growth rate of -41.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 38.93M | 55.66% |
| Dec 31, 2024 | 25.01M | -39.79% |
| Dec 29, 2023 | 41.54M | -54.86% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | -62.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |